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Expressions of tnfsf6 and cyp1a1 and screening related genes by GeneChip on
peripheral blood mononuclear cells in patients with Acute Myocardial Infarction
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Zhou Yijun Karamath, Ma Zhongfu
Department of Emergency, the ﬁrst hospital of Sun Yan-sen University Guangzhou
510080 China
Objectives: Understand the changes in the genes of oxidative stress and the process
of cell toxic with myocardial IRI due to before and after operative of PCI in
STEMI patients. Observe in a dynamic environment the changes in the mRNA
expression of TNFSF6 and CYP1A1 resulting from myocardial IRI and clinical
signiﬁcance.
Methods: Patients admitted to our ER and CCU from November 2011to February
2012. Consisting of 22 patients, 14 males and 8 females, mean age 63.5212.40 years
with a range from 37 to 91years. All cases are diagnosed based on the AMI diagnosis
criteria under Chinese Medical Association in 2003, For patients with normal controls
with age, sex matching healthy volunteers 12 people, 8 male and 4 female, the average
age 57.006.57 (35-68). Acute onset in STEMI group hospital diagnosed after
extracting cubits 10ml were immediately into containing 0.05 ml of heparin without
bacteria. After acute onset of emergency PCI and conventional treatment, the third day
and the seventh day each pump once again were cubits 10ml; The comparison group:
morning, fasting extraction method 10ml were cubits under the same approach as that
for the patients group. PBMCs separation adopts the lymphocyte separate liquid
density gradient centrifugation. Using Human Stress & Toxicity Pathway Finder PCR
Array screening method of myocardial IRI related gene changes. The validation of
expression of CYP1A1 TNFSF6 by Real time PCR. All data to differences with
meanstandard deviation (xs), Value of patients and controls were compared by
ANOVA analysis. And correlation analysis method, the related to P<0.05 to was
statistically signiﬁcant differences.
Results: (1) Of the STEMI group, general average STEMI genes that signiﬁcant
changes in 14, which were up regulated the gene expression of signiﬁcant for 8, were
signiﬁcant down regulated for four genes.The genes expression were up regulated
which are cell growth/aging related genes1 (GADD45A), oxidation stress and meta-
bolic related gene 1 (PRDX2), Heat shock related gene 3 (HSPD1, DNAJB1,
DNAJB2), and repair DNA damage related gene 1 (RAD50), and apoptosis signal
related gene 2 (TNFSF6 TRADD, ) Signiﬁcant down regulated of those genes: the cell
proliferation/cancer related gene 1 (CCNG1), oxidation or metabolic stress related
gene gene 2 (CAT, CYP1A1), DNA damage and restoration related gene 1 (ATM). (2)
The expression of TNFSF6 in STEMI group is higher than of the healthy group and
CYP1A1 was lower than the normal value.
Conclusions: (1) The moderation of multiple genes resulting from myocardial IRI due
to After PCI with Acute myocardial infarction. It provides a more complete view in
the complication and complexity of myocardial IRI gene regulation. (2) The quanti-
tative analysis of TNFSF 6 and CYP1A1 genes after myocardial IRI in AMI at various
stage. They may be involved in the myocardial ischemia/ reperfusion injury physio-
pathological process.
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Analysis of Bacteroides and Biﬁdobacterium diversity in fecal samples from
patients with coronary artery disease by using PCR-denaturing gradient gel
electrophoresis ﬁngerprint
Zhang Yan, Wu Xiaokang, Li Yongqin
Second Afﬁliated Hospital of Medical School, Xi’an Jiaotong University
Objectives: The investigation provides molecular analyses of the faecal microbiota in
coronary artery disease (CAD). This study aimed to clarify the relationship between
CAD and gut predominant microbiota by analyzing the diversity of Bacteroides and
Biﬁdobacterium.
Methods: In order to assess whether there are changes in the diversity and similarity
of gut microbiota in CAD patients when compared with healthy individuals, bacterial
DNAs from 30 CAD and 30 healthy individuals were extracted from faecal samples
and characterised by PCR-denaturing gradient gel electrophoresis (DGGE) with
primers speciﬁcally targeting V3 region of the 16S rRNA gene. After DGGE
proﬁlings was obtained, the diversity and similarity analyses were carried out by the
number of band, Shannon-Weaver (Hp), cluster analysis and the cumulative distri-
bution curve of similarity.
Results: The range of Shannon-Weaver (Hp) in diabetes group and healthy group was
0. 88 (0.74-0.94) and 0. 94 (0.88-0.96) for Bacteroides; 0.84 (0.74-0.93) and 0. 87
(0.73-0.93) for Biﬁdobacterium. The cumulative distribution curve of intra-group
similarity showed that the Dice similarity coefﬁcient (Cs) lower than (or equal to)
0.5 took up 85. 83% of the total Cs for Bacteroides in diabetes group and 35.71% in
healthy group; the Cs lower than (or equal to) 0.4 constituted 90% of the total Cs forJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CBiﬁdobacterium in CAD group and 60.7% in healthy group. It is showed that the
composition of gut microbiota in CAD group might be changed due to atherosclerosis
status.
Conclusions: Sequencing results also revealed that bacterial composition of CAD
group was different from that of the healthy group. DGGE proﬁling has shown
individual speciﬁcity in CAD group and healthy group for Bacteroides and Biﬁdo-
bacterium. The intra-group similarity of Bacteroides and Biﬁdobacterium is lower in
CAD group than in healthy group. Taken together, in this work we observed the
characterisation of gut microbiota in CAD patients, which suggestes that the gut
microbiota of CAD patients have some changes associated with occurrence and
development of CAD.
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Predictive value of serum uric acid level for left atrial thrombus or spontaneous
echo contrast in patients with atrial ﬁbrillation
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Objectives: To investigate the predictive value of serum uric acid (SUA) levels for
left atrial thrombus (LATH)/spontaneous echo contrast (SEC) in patients with atrial
ﬁbrillation (AF).
Methods: The study enrolled 525 patients (Male 337, Female 188, mean age of
60.811.2 years old, 83% paroxysmal AF) with AF who underwent transesophageal
echocardiography (TEE) in Guangdong province cardiovascular institute from July
2007 to January 2013. Patients were categorized into LATH/SEC group (n¼57) and
non-LATH/SEC group (n¼468), according to the TEE results. The clinical baseline of
both groups including age, gender, AF types, SUA levels, indices of echocardiography
and complications were collected and analyzed. The relationships between the
potential risk factors and LATH/SEC were performance using Logistic regression
analysis.
Results: SUA level (391.6398.45umol/L vs 349.2783.93 umol/L, P<0.01), left
atrial diameter (LAD) (41.956.06mm vs 37.445.17mm, P<0.01), proportion of
patients with persistent AF (50.9% vs 13.7%, P<0.01) were signiﬁcantly increased in
patients of LATH/SEC group compared with patients of non-LATH/SEC group. ROC
curve were presented by SUA level, which indicated area under curve was 0.612
(P¼0.006) and the best SUA cut-point was 448.5umol/L. Logistic regression analysis
indicated that female (OR¼2.344, 95% CI 1.228-4.475, P¼0.01), persistent AF
(OR¼5.993, 95% CI 3.127-11.486, P<0.001), SUA level (OR¼2.890, 95% CI 1.380-
6.051, P¼0.005), LAD>40mm (OR¼4.845, 95% CI 2.528-9.284, P<0.001),
CHA2DS2-VASc score (OR¼1.422, 95% CI 1.105-1.829, P¼0.006) were indepen-
dent risk factors of LATH/SEC in patients with AF.
Conclusions: SUA level is independent risk factor and predictive index for LATH/
SEC in patients with AF.
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Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after
acute myocardial infarction in mice
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Objectives: Qiliqiangxin (QL), a traditional Chinese medicine, has been approved by
China Food and Drug Administration for the treatment of chronic heart failure since
2004. Recently, a multicenter randomized double-blind study from our group has
proved that QL reduced the levels of B-type natriuretic peptide (BNP) and N-terminal
pro-B-type natriuretic peptide (NT-proBNP) during 12 weeks of treatment in 512
chronic heart failure patients, suggesting that QL may have a protective effect on
injury heart. However, whether QL can improve cardiac remodeling and the underling
mechanism are still unclear.
Methods: Four groups of C57BL/6 adult male mice (saline plus sham, saline plus
AMI remodeling, QL (0.5g/kg/d) plus sham, and QL (0.5g/kg/d) plus AMI remod-
eling) were randomly divided in this study. Echocardiography and histopathology
were detected to evalute cardiac function and morphological changes. TTC staining
and immunoﬂuorescence were used to test myocardial necrosis and apoptosis.
Quantitative reverse transcription polymerase chain reactions (RT-PCRs) and western
blotting were also used to determine the expression levels of peroxisome proliferator-
activated receptor-a (PPAR-a), -b, - g.
Results: QL signiﬁcantly prevented AMI-induced decreases in ejection fraction (%
EF: MI with saline 38%, MI with QL 48%) and fractional shortening (%FS: MI with
saline 18%, MI with QL 22%) after AMI. In addition, QL decreased myocardial
infarct size by 49% and myocardial apoptosis by 40%. Most imoprtantly, PPARg, a
key regulator for cardiac energy metabolism after myocardial injury, was found to
be down-regulated in AMI remodeling and was up-regulated after QL administra-
tion. A selective PPARg activator Rosiglitazone (at a dose of 1mg/kg/d for 21 days
via intraperitoneal injection) itself had a protective effect on cardiac function after
AMI remodeling. Compared with the administration of QL alone, combination of
PPARg activator with QL did not have signiﬁcant difference on cardiac functionardiovascular-Disciplinary Research C235
